Why are we all still talking about schizophrenia?
We have no idea why we keep talking about it.
But the disease has become a popular topic in our society and a focus of discussion on social media.
For a long time, the disease seemed to be going away, and a new generation of parents started questioning what the heck was going on.
“When I was a little kid I would tell my parents, ‘Well, I am going to be a scientist, and I am really going to study schizophrenia,'” says Lisa Koppelman, an autism and ADHD activist in Washington, D.C. Koppelman has been studying schizophrenia for a decade.
But she says the condition has been a constant presence in her life.
She says the diagnosis came about after she began to have thoughts about her mental health.
“I just started seeing my symptoms, and they became more intense,” she says.
In 2015, she decided to talk about her experiences with the disorder.
“I was just so anxious and stressed out, and it was just really upsetting,” she explains.
“And I knew that if I could just talk about it, and tell people I had schizophrenia, it would help a lot of people.”
“People need to understand that this is not just a mental illness, and that schizophrenia is not like depression or anxiety,” she adds.
There are a number of theories that surround schizophrenia, including that people with the condition have an imbalance in the neurotransmitters serotonin and dopamine.
But Koppell says she is unsure what that imbalance is and why the condition persists.
Another theory is that schizophrenia and bipolar disorder share many of the same underlying brain connections.
It’s also been hypothesized that schizophrenia may be a result of a chemical imbalance that causes cells in the brain to become hyperactive, creating a self-reinforcing cycle that causes the brain’s reward circuitry to be overstimulated.
The same chemical imbalance could also be contributing to the symptoms of bipolar disorder.
This is one of the few mental health conditions that is still being studied, and scientists have been trying to figure out why it has become such a big topic of conversation in the modern world.
“There is a lot more to this illness than we have previously realized,” says Dr. Jennifer Bouchard, a professor of psychiatry at Johns Hopkins University.
“It is a fascinating and complex disorder that affects the brain, and we still do not fully understand how it occurs.”
For now, though, it’s still one of those topics that is going viral.
The disease, which affects between 1 to 6 percent of the population, is thought to be triggered by a chemical called adenosine, which is made in the pineal gland.
It is also found in the brains of those with schizophrenia and those with bipolar disorder, and in the amygdala, a brain region associated with fear.
Bouchard says it is thought that the chemicals that trigger the condition may interact with receptors in the human brain that are found in certain brain regions, such as the amygdala.
This is why we often see symptoms of the disorder in people with bipolar or schizophrenia, and how we see them can also trigger anxiety and panic attacks.
“What’s really important is that we have not been able to find the exact mechanism of the chemical imbalance,” she added.
But the disorder has become the talk of the town, and many have started to question what the underlying chemicals really are, and why they persist.
“But that information is very limited. “
And so the way we treat this condition is not to say, ‘Oh, well, it is a chemical disorder. “
But that information is very limited.
And so the way we treat this condition is not to say, ‘Oh, well, it is a chemical disorder.
Let’s just let it go,'” she says, adding that we are still in the early stages of understanding the exact biochemical pathway that triggers the disorder, even though some researchers are finding it.
Researchers say that the discovery of adenosines may be one of many factors that could help unravel the genetic basis of schizophrenia, but some are concerned that the findings could lead to a new class of drugs that could treat the condition.
While some people with schizophrenia can tolerate adenosin receptor blockers (ARBs), others are much more sensitive to the chemical.
And the drug is currently being studied to see if it might be able to help people with autism, but Bouchards fears that it might cause severe side effects.
What’s your take on this topic?
Related:What is schizophrenia and how can you diagnose it?